Preventive Versus Curative Treatment of Fluid Overload (PCT-Fluid)
Primary Purpose
Respiratory Insufficiency
Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Preventive initiation of fluid removal
Curative initiation of fluid removal
Sponsored by
About this trial
This is an interventional health services research trial for Respiratory Insufficiency
Eligibility Criteria
Inclusion Criteria:
- age>18
- intubation and mechanical ventilation >= 24 hours
- positive cumulated fluid balance or increase in body weight since admission
clinical stability as defined by: 4.1. stable oxygenation (SpO2 ≥ 90 % with FiO2 ≤ 50 % and positive end-expiratory pressure (PEEP) ≤ 8 cm H2O) 4.2. stable hemodynamics (no pressors, no fluid expansion within the last 12 hours) 4.3. stopped or decreased sedation within the last 48 hours and stable neurologic state.
4.4. temperature >36,0 ◦C and < 39◦C
- consent signed by the patient or next of kin or emergency procedure
Exclusion Criteria:
- extracorporal membrane oxygenation
- pregnancy or breastfeeding
- allergy to furosemide, sulfamides or spironolactone
- tracheotomy
- hydrocephaly
- acute right ventricle failure
- cardiac arrest with estimated poor prognosis
- already enrolled in an interventional study on weaning from mechanical ventilation
- Guillain Barre, myasthenia crisis
- planned extubation on the day
- criteria of clinical stability (as described above) present since more than 24 hours
- natremia > 150 mEq/L, kaliemia < 3.5 mEq/L, metabolic alkalosis with pH>7.5
- administration of iodinated contrast within the last 6 hours
- ongoing or planned use of artificial kidney within the next 48 hours
- no affiliation to the health insurance system
- patient under curatorship
- imprisoned patient
Sites / Locations
- GH Pitié Salpêtrière - Charles FoixRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Other
Arm Label
1
2
Arm Description
Preventive initiation of fluid removal
Curative initiation of fluid removal
Outcomes
Primary Outcome Measures
Duration of weaning from mechanical ventilation
Time elapsed between the day of randomization and the day of successful extubation (patient alive without reintubation 7 days after extubation)
Secondary Outcome Measures
Percentage of patients with metabolic complications
At least one among hypernatremia (>150 mEq/L), hypokaliemia (<2.5 mEq/L) or kidney injury (KDIGO classification stades 2 et 3)
Percentage of patients with hemodynamic complications
At least one among hypotension with systolic blood pressure <90 mmHg, introduction or increase in vasopressors dose, use of fluid expansion, atrial fibrillation, ventricular fibrillation
Daily and cumulated fluid balance
Difference between fluids intake and output (mL)
Rate of patients who failed the first spontaneous breathing trial
Failure of the first spontaneous breathing trial defined according to international guidelines
Rate of reintubation
Rate of patients who have been reintubated on the basis of predefined criteria (coma, cardiac or respiratory arrest, shock, post extubation acute respiratory distress)
Rate of tracheotomy
Decision of tracheotomy by the attending physician
Percentage of patients with use of unplanned non invasive ventilation (NIV) and high flow nasal cannula (HFNC) oxygen
Decision of use of NIV and HFNC by the attending physician, based on the international guidelines
Ventilator free days
Number of ventilator free days
Total number of days of mechanical ventilation
Number of days from intubation to successful extubation (patient alive without reintubation within 7 days after extubation)
Percentage of patients with ventilator associated pneumonia
as per consensus definition: presence of the 3 criteria:
Clinical suspicion (temperature> 38.3 ° C, leukocytosis (> 12000 / mm3) or leukopenia (<4000 / mm3), hypoxemia, auscultatory signs, or septic shock without obvious focus
New radiological infiltrate
Positive respiratory sampling in culture (quantitative or non-quantitative)
Duration of stay in the ICU
Time elapse from ICU admission to ICU discharge
Duration of stay in the hospital
Time elapse from hospital admission to hospital discharge
Percentage of deaths in the ICU among patients
Full Information
NCT ID
NCT04050007
First Posted
August 6, 2019
Last Updated
July 19, 2021
Sponsor
Assistance Publique - Hôpitaux de Paris
1. Study Identification
Unique Protocol Identification Number
NCT04050007
Brief Title
Preventive Versus Curative Treatment of Fluid Overload
Acronym
PCT-Fluid
Official Title
Effect of a Systematic Preventive Versus Curative Strategy of Fluid Removal on the Weaning of Mechanical Ventilation
Study Type
Interventional
2. Study Status
Record Verification Date
July 2021
Overall Recruitment Status
Unknown status
Study Start Date
February 1, 2020 (Actual)
Primary Completion Date
March 1, 2022 (Anticipated)
Study Completion Date
December 1, 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Fluid overload is associated with a poor prognosis in critically ill patients, especially during weaning from mechanical ventilation as it may promote weaning induced pulmonary edema. Previous data suggest that early administration of diuretics ("preventive depletion") could shorten the duration of mechanical ventilation. However, this strategy may expose patients to a risk of metabolic complications. On the other hand, initiating fluid removal only in case of weaning induced pulmonary edema (curative depletion) may reduce the risk of metabolic complications, but prolong the duration of mechanical ventilation. Currently, there is no recommendation for a preventive or curative use of diuretics during weaning. There is therefore an equipoise on the timing of initiation of diuretics during weaning from mechanical ventilation.
Detailed Description
Mechanical ventilation is a cornerstone treatment for critically ill patients that is however associated with complications that may alter the prognosis. A major objective is therefore to separate patients from the ventilator as quickly as possible, but without exposing them to the risk of extubation failure. Pulmonary edema is a frequent cause of extubation failure (up to 60% in recent series) and a positive fluid balance has been identified as an important risk factor for extubation failure.
Studies have tested the effect of a conservative strategy regarding the administration of fluids in patients with acute respiratory distress syndrome. This strategy is associated with an improvement in hemodynamic parameters despite an increase in urine output with a negative fluid balance and a significant weight loss as compared to a liberal strategy. The conservative approach also shows a significant improvement in oxygenation with a nonsignificant trend towards a shorter duration of artificial ventilation and ICU stay. During the specific phase of weaning from mechanical ventilation, a randomized trial (BMW trial) demonstrated that a strategy of fluid removal guided by measurement of the plasmatic B-type natriuretic peptide significantly reduced the duration of weaning. Likewise, the interest of obtaining a negative fluid balance through the administration of diuretics in weaning induced pulmonary edema has been established for decades ("curative depletion").
In this context, the hypothesis of the present study is that a preventive and systematic strategy of fluid removal through the use of diuretics initiated just before the weaning phase, as soon as the patients is stabilized would shorten the duration of weaning from mechanical ventilation as compared to a curative strategy of fluid removal, only initiated after a failure of the spontaneous breathing trial associated with weaning induced pulmonary edema.
The design of the study will be a randomized (1:1) controlled trial, open label, with 2 arms, to evaluate the superiority of the preventive strategy.
The weaning process will be protocolized and similar for the two groups.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Respiratory Insufficiency
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
410 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Experimental
Arm Description
Preventive initiation of fluid removal
Arm Title
2
Arm Type
Other
Arm Description
Curative initiation of fluid removal
Intervention Type
Other
Intervention Name(s)
Preventive initiation of fluid removal
Intervention Description
Preventive initiation of fluid removal will be started right after the randomization with intravenous diuretics according to a predefined algorithm based on the urine output every three hours.
The weaning process and post extubation preventive strategy will be protocolized based on the last international guidelines
Intervention Type
Other
Intervention Name(s)
Curative initiation of fluid removal
Intervention Description
The initiation of fluid removal will be considered by the attending physician only in case of failure to the spontaneous breathing trial with a clinical suspicion of weaning induced pulmonary edema.
The weaning process and post extubation preventive strategy will be protocolized based on the last international guidelines
Primary Outcome Measure Information:
Title
Duration of weaning from mechanical ventilation
Description
Time elapsed between the day of randomization and the day of successful extubation (patient alive without reintubation 7 days after extubation)
Time Frame
28 days
Secondary Outcome Measure Information:
Title
Percentage of patients with metabolic complications
Description
At least one among hypernatremia (>150 mEq/L), hypokaliemia (<2.5 mEq/L) or kidney injury (KDIGO classification stades 2 et 3)
Time Frame
28 days
Title
Percentage of patients with hemodynamic complications
Description
At least one among hypotension with systolic blood pressure <90 mmHg, introduction or increase in vasopressors dose, use of fluid expansion, atrial fibrillation, ventricular fibrillation
Time Frame
28 days
Title
Daily and cumulated fluid balance
Description
Difference between fluids intake and output (mL)
Time Frame
28 days
Title
Rate of patients who failed the first spontaneous breathing trial
Description
Failure of the first spontaneous breathing trial defined according to international guidelines
Time Frame
28 days
Title
Rate of reintubation
Description
Rate of patients who have been reintubated on the basis of predefined criteria (coma, cardiac or respiratory arrest, shock, post extubation acute respiratory distress)
Time Frame
7 days
Title
Rate of tracheotomy
Description
Decision of tracheotomy by the attending physician
Time Frame
28 days
Title
Percentage of patients with use of unplanned non invasive ventilation (NIV) and high flow nasal cannula (HFNC) oxygen
Description
Decision of use of NIV and HFNC by the attending physician, based on the international guidelines
Time Frame
7 days
Title
Ventilator free days
Description
Number of ventilator free days
Time Frame
At 14 days and 28 days
Title
Total number of days of mechanical ventilation
Description
Number of days from intubation to successful extubation (patient alive without reintubation within 7 days after extubation)
Time Frame
28 days
Title
Percentage of patients with ventilator associated pneumonia
Description
as per consensus definition: presence of the 3 criteria:
Clinical suspicion (temperature> 38.3 ° C, leukocytosis (> 12000 / mm3) or leukopenia (<4000 / mm3), hypoxemia, auscultatory signs, or septic shock without obvious focus
New radiological infiltrate
Positive respiratory sampling in culture (quantitative or non-quantitative)
Time Frame
28 days
Title
Duration of stay in the ICU
Description
Time elapse from ICU admission to ICU discharge
Time Frame
28 days
Title
Duration of stay in the hospital
Description
Time elapse from hospital admission to hospital discharge
Time Frame
28 days
Title
Percentage of deaths in the ICU among patients
Time Frame
28 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
age>18
intubation and mechanical ventilation >= 24 hours
positive cumulated fluid balance or increase in body weight since admission
clinical stability as defined by: 4.1. stable oxygenation (SpO2 ≥ 90 % with FiO2 ≤ 50 % and positive end-expiratory pressure (PEEP) ≤ 8 cm H2O) 4.2. stable hemodynamics (no pressors, no fluid expansion within the last 12 hours) 4.3. stopped or decreased sedation within the last 48 hours and stable neurologic state.
4.4. temperature >36,0 ◦C and < 39◦C
consent signed by the patient or next of kin or emergency procedure
Exclusion Criteria:
extracorporal membrane oxygenation
pregnancy or breastfeeding
allergy to furosemide, sulfamides or spironolactone
tracheotomy
hydrocephaly
acute right ventricle failure
cardiac arrest with estimated poor prognosis
already enrolled in an interventional study on weaning from mechanical ventilation
Guillain Barre, myasthenia crisis
planned extubation on the day
criteria of clinical stability (as described above) present since more than 24 hours
natremia > 150 mEq/L, kaliemia < 3.5 mEq/L, metabolic alkalosis with pH>7.5
administration of iodinated contrast within the last 6 hours
ongoing or planned use of artificial kidney within the next 48 hours
no affiliation to the health insurance system
patient under curatorship
imprisoned patient
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Martin DRES
Phone
+33142167888
Email
martin.dres@aphp.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Armand MEKONTSO DESSAP
Phone
+33149812390
Email
armand.dessap@aphp.fr
Facility Information:
Facility Name
GH Pitié Salpêtrière - Charles Foix
City
Paris
ZIP/Postal Code
75013
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Martin DRES
First Name & Middle Initial & Last Name & Degree
Martin DRES, Dr
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Data are available upon reasonable request. The procedures carried out with the French data privacy authority (CNIL, Commission Nationale de l'Informatique et des Libertés) do not provide for the transmission of the database, nor do the information and consent documents signed by the patients.
Consultation by the editorial board or interested researchers of individual participant data that underlie the results reported in the article after deidentification may nevertheless be considered, subject to prior determination of the terms and conditions of such consultation and in respect for compliance with the applicable regulations.
IPD Sharing Time Frame
Beginning 3 months and ending 3 years following article publication. Requests out of these time frame can also be submitted to the sponsor
IPD Sharing Access Criteria
Researchers who provide a methodologically sound proposal
Citations:
PubMed Identifier
34400454
Citation
Dres M, Estellat C, Baudel JL, Beloncle F, Cousty J, Galbois A, Guerin L, Labbe V, Labro G, Lebut J, Mira JP, Prat G, Quenot JP, Dessap A; Reseau Europeen de Recherche en Ventilation Artificielle (REVA) research network. Comparison of a preventive or curative strategy of fluid removal on the weaning of mechanical ventilation: a study protocol for a multicentre randomised open-label parallel-group trial. BMJ Open. 2021 Aug 16;11(8):e048286. doi: 10.1136/bmjopen-2020-048286.
Results Reference
derived
Learn more about this trial
Preventive Versus Curative Treatment of Fluid Overload
We'll reach out to this number within 24 hrs